Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer

A.R. Hanauske, M. Lahn, L.C. Musib, K. Weigang-Koehler, E. Yilmaz, T. Graefe, B.C. Kuenen, D. Thornton, P. McNealy, G. Giaccone

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1565-1575
JournalAnnals of Oncology
Issue number9
Publication statusPublished - 2009

Cite this